USANA Health Sciences, Inc.
USNA
$16.96
-$0.19-1.08%
NYSE
| 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/28/2024 | |
|---|---|---|---|---|---|
| Net Income | -139.85% | -161.49% | -7.45% | -43.15% | -73.43% |
| Total Depreciation and Amortization | 74.81% | 72.10% | 68.43% | 101.51% | 20.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 561.71% | 24.09% | 27.53% | -29.40% | -79.41% |
| Change in Net Operating Assets | -230.38% | -227.18% | 2.78% | 17.35% | -2,423.39% |
| Cash from Operations | -158.60% | -106.64% | 52.92% | -12.45% | -77.77% |
| Capital Expenditure | -55.11% | -33.31% | -88.21% | 12.43% | 75.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -23.11% | -23.22% | -- |
| Cash from Investing | 100.54% | -36.78% | -169.21% | 4.74% | -2,701.67% |
| Total Debt Issued | -30.43% | 100.00% | 938.96% | -- | 2,803.79% |
| Total Debt Repaid | -33,433.33% | -100.00% | -1,566.67% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 24.32% | -26.58% | -49,032.26% | -15.89% | 44.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -41.33% | -1,155.13% | -2,753.66% | -21.10% | 3,384.80% |
| Foreign Exchange rate Adjustments | 128.11% | -96.97% | 326.32% | 118.88% | -267.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.14% | -118.34% | -794.05% | -0.05% | -882.28% |